Stocks and Investing
Stocks and Investing
Thu, January 5, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tony Butler Initiated (ADAP) at Strong Buy and Held Target at $10 on, Jan 5th, 2023
Tony Butler of EF Hutton, Initiated "Adaptimmune Therapeutics plc" (ADAP) at Strong Buy and Held Target at $10 on, Jan 5th, 2023.
Tony has made no other calls on ADAP in the last 4 months.
There are 4 other peers that have a rating on ADAP. Out of the 4 peers that are also analyzing ADAP, 2 agree with Tony's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Yanan Zhu of "Wells Fargo" Maintained at Hold with Increased Target to $3 on, Monday, November 14th, 2022
- Nick Abbott of "Wells Fargo" Maintained at Hold with Decreased Target to $1.5 on, Tuesday, October 4th, 2022
These are the ratings of the 2 analyists that currently disagree with Tony
- Michael Schmidt of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $5 on, Tuesday, January 3rd, 2023
- Mara Goldstein of "Mizuho" Upgraded from Hold to Strong Buy and Held Target at $9 on, Wednesday, November 9th, 2022
Contributing Sources